Cisadane Sawit Raya Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Cisadane Sawit Raya Tbk trades at Rp760 (market cap 1.57T, 62.2K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Cisadane Sawit Raya Tbk is far larger — about 9.4× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (71K versus 62.2K). Which is the better fit depends on your goals.
| CSRA | OBAT | |
|---|---|---|
Market Cap | 1.57T | 167.37B |
Volume | 62.2K | 71K |
Lot | 622 | 710 |
Turnover | 47.36M | 17.51M |
Average Price | 761.35 | 246.63 |
Value | 47.36M | 17.51M |
Indicative Equilibrium Price | 765 | 246 |
Indicative Equilibrium Volume | 100 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cisadane Sawit Raya Tbk (the Company) was established based on Notarial Deed No. 82 dated October 28, 1983 of Public Notary Erly Soehandjojo, S.H., amended by Notarial Deed No. 107 dated November 25, 1987 of Public Notary H.Z. Simon, S.H.
Read more on CSRA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →